{"id":"W4404619686","doi":"10.1136/bmjopen-2024-086055","title":"Anifrolumab Study for Treatment Effectiveness in the Real World (ASTER) among patients with systemic lupus erythematosus: protocol for an international observational effectiveness study","year":2024,"lang":"en","type":"article","venue":"BMJ Open","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Idorsia Pharmaceuticals; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Ustekinumab; Internal medicine; Tolerability; Population; Medical prescription; Disease; Intensive care medicine; Adverse effect; Infliximab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0597283,0.004712302,0.006148591,0.002626782,0.002459186,0.004050006,0.003544564,0.004094806,0.03280911],"category_scores_gemma":[0.04510924,0.00210147,0.007165804,0.004005302,0.002430294,0.0040827,0.002708905,0.004955351,0.006216934],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005190031,"about_ca_system_score_gemma":0.01066993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001856128,"about_ca_topic_score_gemma":0.002962788,"domain_scores_codex":[0.9525376,0.03380329,0.006453909,0.002934398,0.00249847,0.001772384],"domain_scores_gemma":[0.9671381,0.008980039,0.009249951,0.004263387,0.008182202,0.002186326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7940997,0.01643328,0.01432911,0.04002446,0.009701613,0.000613966,0.001969952,0.005023492,0.002324744,0.00889975,0.05699242,0.04958745],"study_design_scores_gemma":[0.7600492,0.0384583,0.04911211,0.01103159,0.00449503,0.0003606069,0.001277086,0.005489697,0.001813055,0.005687781,0.1218485,0.0003769762],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.004544541,0.0004379973,0.002355197,0.0002531737,0.0001996209,0.9833727,0.006962079,0.00006807538,0.001806647],"genre_scores_gemma":[0.003764456,0.00009645037,0.002284981,0.0001182354,0.00002885176,0.9923164,0.00119237,0.000007929044,0.0001903459],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.0597283,"threshold_uncertainty_score":0.3158773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1479679007027619,"score_gpt":0.4749100176421603,"score_spread":0.3269421169393983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}